Technetium (99mTc) votumumab

Technetium (99mTc) votumumab
Monoclonal antibody
Type Whole antibody
Source Human
Target tumor antigen CTAA16.88
Clinical data
ATC code V09IA04 (WHO)
Legal status
Legal status
  • not marketed
CAS Number 148189-70-2 N
ChemSpider none
 NYesY (what is this?)  (verify)

Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1] It was developed for the detection of colorectal tumors, but has never been marketed.[2]

The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.[3]


This article is issued from Wikipedia - version of the 9/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.